Fear of cancer recurrence in long-term post-menopausal breast cancer women: evidence from the French national VICAN survey
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-10094-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Anne-Déborah Bouhnik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Aix Marseille Univ, Marseille, Fran…. Hauptthemen laut MEDLINE: Breast Neoplasms, Fear, Postmenopause, Neoplasm Recurrence, Local. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: The purpose of this study is to estimate the prevalence and factors associated with fear of cancer recurrence (FCR) in post-menopausal women 5 years after the diagnosis of breast cancer (BC). METHODS: Using data from the VICAN-5 survey, we included women with non-metastatic BC, aged 55 years or more at diagnosis, who had not experienced disease progression in the 5 years post-diagnosis. Multinomial logistic regression was used to identify factors associated with FCR, characterized using a three-level indicator: no, mild, and moderate/severe FCR derived from a single item. RESULTS: Among the 382 women included, the mean age was 66 years at diagnosis. Five years later, 38% of women were still receiving adjuvant endocrine therapy (AET), and 27% were no longer on AET. Overall, 34.8% reported mild FCR, and 14.2% reported moderate/severe FCR. Cancer-related sequelae, anxiety, and a decrease in physical activity were associated with mild or moderate/severe FCR. Moderate/severe FCR was also more often reported by women still on AET experiencing significant side effects and those who had never taken AET. Mild FCR was more frequent in the two-thirds of women consulting a GP for the management of their cancer. CONCLUSION: Moderate/severe FCR affected one out of seven post-menopausal BC survivors 5 years after diagnosis, particularly those with anxiety, cancer sequelae, physical limitations, significant side effects of AET, but also among those who had never taken AET. BC survivors should be informed of long-term side effects of treatments, in particular AET, to help them cope with ongoing symptoms and related FCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Aix Marseille Univ, Marseille, France. anne-deborah.bouhnik@inserm.fr.
- The Daffodil Centre, The University of Sydney, A Joint Venture With Cancer Council NSW, Sydney, NSW, Australia.
- Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Aix Marseille Univ, Marseille, France.
- Aix Marseille Univ, Marseille, France.
- Unité UMR 1296, Radiations: Défense, Santé, Environnement, Lyon, France.
- Institut de Psychologie, Université Lumière Lyon 2, Bron, France.
Zitieren
APA
Bouhnik, A. D., Smith, A. B., Bendiane, M. K., Magnani, C., Rey, D., Préau, M., Sarradon-Eck, A., & Mancini, J. (2025). Fear of cancer recurrence in long-term post-menopausal breast cancer women: evidence from the French national VICAN survey. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10094-8
Vancouver
Bouhnik AD, Smith AB, Bendiane MK, Magnani C, Rey D, Préau M, et al. Fear of cancer recurrence in long-term post-menopausal breast cancer women: evidence from the French national VICAN survey. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-10094-8
BibTeX
@article{Bouhnik2025,
author = {Bouhnik, Anne-Déborah and Smith, Allan Ben and Bendiane, Marc-Karim and Magnani, Clément and Rey, Dominique and Préau, Marie and Sarradon-Eck, Aline and Mancini, Julien},
title = {Fear of cancer recurrence in long-term post-menopausal breast cancer women: evidence from the French national VICAN survey},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-10094-8}
}
EUVIMED